
---
sidebar_position: 11
---
        <h3>making-available-on-the-market-and-putting--into-service-of-devices-obligations-of-economic-operators--reprocessing-ce-marking-free-movement</h3>
<h1>Change-of-authorised-representative</h1>
<h2>Article 12</h2>
   <p class="stitle-article-norm">Change of authorised representative</p>
   <p class="norm">The detailed arrangements for a change of authorised 
representative shall be clearly defined in an agreement between the 
manufacturer, where practicable the outgoing authorised representative, 
and the incoming authorised representative. That agreement shall address
 at least the following aspects:</p>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(a)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the date of termination of the mandate of the 
outgoing authorised representative and date of beginning of the mandate 
of the incoming authorised representative;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(b)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the date until which the outgoing authorised 
representative may be indicated in the information supplied by the 
manufacturer, including any promotional material;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(c)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the transfer of documents, including confidentiality aspects and property rights;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(d)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the obligation of the outgoing authorised 
representative after the end of the mandate to forward to the 
manufacturer or incoming authorised representative any complaints or 
reports from healthcare professionals, patients or users about suspected
 incidents related to a device for which it had been designated as 
authorised representative.</p>
      </div>
   </div>